Claudio Salvatore Cartia
Claudio Salvatore Cartia publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes and Protein Degradation and Inhibitors.
- World rank
- #5,216,555 of 7,710,434 ranked researchers
- Rank in Italy
- #175,158 of 242,206
- Works
- 30
- Citations
- 168
- Citations per work
- 5.6
What does Claudio Salvatore Cartia research?
Claudio Salvatore Cartia's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1963.9%
- Medicine1963.9%
- Life Sciences621.3%
- Everything else414.8%
- 1Hematology31% of their works
- 2Molecular Biology21% of their works
- 3Oncology15% of their works
- 4Genetics9% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Infectious Diseases4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Protein Degradation and Inhibitors
- Peptidase Inhibition and Analysis
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cancer Treatment and Pharmacology
- Cancer Mechanisms and Therapy
Which keywords describe Claudio Salvatore Cartia's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, Cardiac Amyloidosis, Transthyretin, BET Bromodomains, Fibroblast Activation Protein, PROTACs and Tumor Microenvironment.
- Tumorigenesis
- Pim Oncogenes
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- Tumor Microenvironment
- Fibroblast Activation Protein
- Transthyretin
- International Myeloma Working Group
- Diagnosis Criteria
- Cardiac Amyloidosis
- BET Bromodomains
- PROTACs
- Chemotherapy-Induced Peripheral Neuropathy
- Genomic Aberrations
- Myelofibrosis
- Taxanes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Diagnosis Criteria221 topic
- International Myeloma Working Group221 topic
- Cardiac Amyloidosis71 topic
- Transthyretin71 topic
- BET Bromodomains61 topic
- Fibroblast Activation Protein61 topic
- PROTACs61 topic
- Tumor Microenvironment61 topic
- Chemotherapy-Induced Peripheral Neuropathy31 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- JAK2 Mutation31 topic
- Myelofibrosis31 topic
- Pim Oncogenes31 topic
- Taxanes31 topic
- Tumorigenesis31 topic
Where does Claudio Salvatore Cartia work?
Claudio Salvatore Cartia's main affiliation in the publication record is Policlinico San Matteo Fondazione, Italy.
How many publications and citations does Claudio Salvatore Cartia have?
OpenAlex counts 30 works and 168 citations for Claudio Salvatore Cartia, an h-index of 6, ranking #5,216,555 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Claudio Salvatore Cartia. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.